Recent calls for the government to lower prescription drug prices by overriding patent rights include proposals for the establishment of a marginal cost pricing system in the pharmaceutical industry (and […]
[Archived Post] Arts & Entertainment Advocacy Clinic Students File Amicus Brief in Brammer v. Violent Hues
By Rachelle Mortimer & Grant Ossler* The Arts & Entertainment Advocacy Clinic at Antonin Scalia Law School recently filed an amicus brief in the Brammer v. Violent Hues case that […]
[Archived Post] A Cure Worse Than the Disease? Proposed Changes to European Patent Law are Threatening Pharmaceutical Innovation
Innovation is all around us. We love and appreciate the latest video games, software apps, and smartphones. We await the integration of self-driving cars and other forms of artificial intelligence. […]
[Archived Post] Proposed Misuse of Section 1498 Relies on the False Claim that Patents Are Not Property
By Kathleen Wills* The question whether patents are property rights is a continuing and hotly debated topic in IP law. Despite an abundance of scholarship (see here, here, here, here, […]
[Archived Post] VIDEOS: Panel Presentations from the CPIP 2018 Fall Conference
On October 11-12, 2018, CPIP hosted its Sixth Annual Fall Conference, IP for the Next Generation of Technology, at Antonin Scalia Law School, George Mason University, in Arlington, Virginia. After […]
[Archived Post] Proposal for Drug Price Controls is Legally Unprecedented and Threatens Medical Innovation
By Adam Mossoff, Sean O’Connor, & Evan Moore* The price of the miracle drugs everyone uses today is cause for concern among people today. The President has commented on it. […]